Source: BioPortfolio

NBE Therapeutics: NBETherapeutics AG Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 23042018 Prices from USD $250

SummaryNBETherapeutics AG NBETherapeutics is a biotechnology company that focuses on the development of antibody drug conjugates ADC to improve the treatment of cancer. ADCs act against cancer cells via tumorspecific antibodies and deliver powerful cellula...

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Est. Annual Revenue
Est. Employees
Bertrand Damour's photo - CEO of NBE Therapeutics

CEO

Bertrand Damour

CEO Approval Rating

90/100

NBE Therapeutics is a biotechnology company that develops and commercializes antibody-drug conjugates for the treatment of cancer. Read more